[1] Page RC, Offenbacher S, Schroeder HE, et al. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions [J]. Periodontol 2000, 1997, 14: 216-248. [2] Chen ZW, Yi HY, Hang HL, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus [J]. BMC Oral Health, 2020, 20(1): 204. [3] Bonnelye E, Chabadel A, Saltel F, et al. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro [J]. Bone, 2008, 42(1): 129-138. [4] Yogui FC, Ervolino-Silva AC, Pitol-Palin L, et al. Strontium ranelate promotes increased peri-implant bone formation in ovariectomized rats [J]. Res Society Development, 2020, 9(10): e7539109092. [5] Kirschneck C, Wolf M, Reicheneder C, et al. Strontium ranelate improved tooth anchorage and reduced root resorption in orthodontic treatment of rats [J]. Eur J Pharmacol, 2014, 744: 67-75. [6] Karakan NC, Akpınar A, Göze F, et al. Investigating the effects of systemically administered strontium ranelate on alveolar bone loss histomorphometrically and histopathologically on experimental periodontitis in rats [J]. J Periodontol, 2017, 88(2): e24-e31. [7] Marins LM, Napimoga MH, Malta FDS, et al. Effects of strontium ranelate on ligature-induced periodontitis in estrogen-deficient and estrogen-sufficient rats [J]. J Periodontal Res, 2019, 55(1): 141-151. [8] Sun HY, Jiang H, Du MQ, et al. The prevalence and associated factors of periodontal disease among 35 to 44-year-old Chinese adults in the 4th national oral health survey [J]. Chin J Dent Res, 2018, 21(4): 241-247. [9] Rizzoli R, Chapurlat RD, Laroche JM, et al. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis [J]. Osteoporos Int, 2012, 23(1): 305-315. [10] Liu W, Zhang X. Receptor activator of nuclear factor-κB ligand (RANKL)/ RANK/ osteoprotegerin system in bone and other tissues [J]. Mol Med Rep, 2015, 11(5): 3212-3218. [11] Wang S, Xu S, Shi Z, et al. Progress of research on the relationship between calcitonin gene-related peptide and RANK/RANKL/OPG system in the bone reconstruction [J]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2019, 33(4): 511-515. [12] Amin N, Boccardi V, Taghizadeh M, et al. Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway [J]. Aging Clin Exp Res, 2020, 32(3): 363-371. [13] Van Driel M, Van Leeuwen JP. Strontium ranelate promotes osteoblast differentiation and increases Opg/Rankl ratio in osteoblast-osteoclast co-cultures [J]. Bone, 2010, 47(1): s134. [14] 王冰,徐又佳,郝彦明,等.去卵巢和激素致骨质疏松模型中骨密度与血清指标的比较[J].苏州大学学报(医学版),2008,28(1): 10-13. [15] Nizet A, Cavalier E, Stenvinkel P, et al. Bone alkaline phosphatase: An important biomarker in chronic kidney disease-mineral and bone disorder [J]. Clin Chim Acta, 2020, 501: 198-206. |